رجوع
55
75
مُدرج أيضًا باسم
WXXWY
OTC
نطاق اليوم
KWD 4.60
KWD 5.26
نطاق 52 أسبوعًا
KWD 2.26
KWD 5.61
حجم التداول
32,250
متوسط 50 يوم / 200 يوم
KWD 4.71
/
KWD 4.34
الإغلاق السابق
KWD 4.60
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Healthcare (626 نظير)
| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | 5.7 | 0.4 |
| P/B | 0.5 | 2.9 |
| ROE % | 8.2 | 3.7 |
| Net Margin % | 18.0 | 3.8 |
| Rev Growth 5Y % | 35.1 | 10.0 |
| D/E | 0.1 | 0.2 |
النقاط الرئيسية
Revenue grew 35.06% annually over 5 years — strong growth
Net margin of 17.97% shows strong profitability
Debt/Equity of 0.12 — conservative balance sheet
Generating 1.29B in free cash flow
P/E of 5.66 — trading at a low valuation
Revenue growth is decelerating — 1Y growth trails 5Y average by 25.43%
النمو
Revenue Growth (5Y)
35.06%
Revenue (1Y)9.63%
Earnings (1Y)-1.28%
FCF Growth (3Y)N/A
الجودة
Return on Equity
8.17%
ROIC7.98%
Net Margin17.97%
Op. Margin26.63%
الأمان
Debt / Equity
0.12
Current Ratio2.73
Interest Coverage31.56
التقييم
P/E Ratio
5.66
P/B Ratio0.45
EV/EBITDA3.15
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 9.63% | Revenue Growth (3Y) | 10.59% |
| Earnings Growth (1Y) | -1.28% | Earnings Growth (3Y) | -12.87% |
| Revenue Growth (5Y) | 35.06% | Earnings Growth (5Y) | 18.73% |
| Profitability | |||
| Revenue (TTM) | 18.68B | Net Income (TTM) | 3.36B |
| ROE | 8.17% | ROA | 5.89% |
| Gross Margin | 40.97% | Operating Margin | 26.63% |
| Net Margin | 17.97% | Free Cash Flow (TTM) | 1.29B |
| ROIC | 7.98% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.12 | Current Ratio | 2.73 |
| Interest Coverage | 31.56 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | 5.66 | P/B Ratio | 0.45 |
| P/S Ratio | 1.02 | PEG Ratio | 15.60 |
| EV/EBITDA | 3.15 | Dividend Yield | 0.00% |
| Market Cap | 18.99B | Enterprise Value | 15.65B |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 18.68B | 17.03B | 15.27B | 10.29B | 5.61B |
| Net Income | 3.36B | 3.40B | 4.42B | 3.39B | 1.69B |
| EPS (Diluted) | 0.78 | 0.77 | 1.01 | 0.77 | 0.40 |
| Gross Profit | 7.65B | 6.83B | 6.72B | 4.83B | 2.53B |
| Operating Income | 4.97B | 4.45B | 4.34B | 3.19B | 1.50B |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 56.98B | 56.58B | 49.56B | 44.03B | 28.96B |
| Total Liabilities | 11.50B | 12.56B | 13.35B | 11.33B | 8.06B |
| Shareholders' Equity | 41.82B | 40.33B | 35.05B | 32.28B | 20.56B |
| Total Debt | 4.94B | 4.56B | 4.42B | 4.30B | 3.33B |
| Cash & Equivalents | 8.28B | 9.67B | 6.40B | 9.00B | 7.10B |
| Current Assets | 23.57B | 21.20B | 18.47B | 19.53B | 14.20B |
| Current Liabilities | 8.62B | 7.64B | 9.32B | 8.26B | 4.50B |
درجات الاستراتيجيات
This stock passed the criteria for 2 strategies
Score = fit strength (0–100)
Rank = position among all matches
#218 of 820
#13 of 708
النشاط الأخير
دخل
Deep Value Investing (Seth Klarman)
Mar 24, 2026
دخل
Defensive Investing (Benjamin Graham)
Mar 24, 2026